Shaperon Inc.
Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.
378800 | KO
Overview
Corporate Details
- ISIN(s):
- KR7378800007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 자곡로 174-10 강남에이스타워 606호(자곡동), 서울특별시
- Website:
- https://www.shaperon.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Shaperon Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for inflammatory diseases and cancer. The company specializes in creating innovative inflammasome inhibitors, utilizing a unique mechanism of action involving GPCR19-P2X7 modulation to suppress immune responses. Its development pipeline targets conditions such as atopic dermatitis and other immune-mediated inflammatory disorders. In addition to small molecules, Shaperon develops nanobody therapeutics for cancer immunotherapy, leveraging proprietary immunized libraries and high-throughput screening technologies. Founded in 2008, the company completed a successful initial public offering in October 2022.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-16 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 86.0 KB | ||
| 2025-09-16 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.0 KB | ||
| 2025-09-16 00:00 | Share Issue/Capital Change 유상증자1차발행가액결정              (주주배정후 실권주 일반공모) | Korean | 7.6 KB | ||
| 2025-09-16 00:00 | Share Issue/Capital Change [기재정정]주요사항보고서(유상증자결정) | Korean | 40.4 KB | ||
| 2025-09-16 00:00 | Registration Form [발행조건확정]증권신고서(지분증권) | Korean | 435.2 KB | ||
| 2025-09-16 00:00 | Prospectus 투자설명서 | Korean | 2.7 MB | ||
| 2025-09-16 00:00 | Share Issue/Capital Change 권리락              (유상증자) | Korean | 3.5 KB | ||
| 2025-09-12 00:00 | Director's Dealing 임원ㆍ주요주주특정증권등거래계획보고서 | Korean | 42.6 KB | ||
| 2025-09-01 00:00 | Registration Form [기재정정]증권신고서(지분증권) (2025.10) | Korean | 3.2 MB | ||
| 2025-08-18 00:00 | Share Issue/Capital Change 주요사항보고서(유상증자결정) | Korean | 32.0 KB | ||
| 2025-08-18 00:00 | Registration Form 증권신고서(지분증권) (2025.10) | Korean | 2.5 MB | ||
| 2025-08-14 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 1.4 MB | ||
| 2025-05-15 00:00 | Quarterly Report 분기보고서 (2025.03) | Korean | 1.1 MB | ||
| 2025-03-26 00:00 | Post-Annual General Meeting Information [기재정정]정기주주총회결과               | Korean | 31.2 KB | ||
| 2025-03-26 00:00 | Board/Management Information [기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고 | Korean | 13.4 KB | 
Automate Your Workflow. Get a real-time feed of all Shaperon Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Shaperon Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shaperon Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    